Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice

被引:124
作者
Ostos, MA
Conconi, M
Vergnes, L
Baroukh, N
Ribalta, J
Girona, J
Caillaud, JM
Ochoa, A
Zakin, MM
机构
[1] Inst Pasteur, Unite Express Genes Eucaryotes, F-75724 Paris 15, France
[2] Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, Paris, France
[3] Univ Rovira & Virgili, Unitat Recerca Lipids & Arteriosclerosis, Reus, Spain
[4] Rhone Poulenc Rorer, Vitry Sur Seine, France
关键词
antioxidants; apolipoprotein A-IV; atherosclerosis; transgenic mice;
D O I
10.1161/01.ATV.21.6.1023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mice expressing human apolipoprotein A-IV (apoA-IV) mainly in the intestine were obtained in an apolipoprotein E-deficient (apoE(o)) background (apoA-IV/E-o mice). Quantification of aortic lesions and plasma lipid determination showed that compared with their control apoE(o) counterparts, the apoA-IVIE, mice are protected against atherosclerosis without an increase in HDL cholesterol, Because oxidized lipoproteins play an important role in atherogenesis, we tested whether the protection observed in these animals is accompanied by an in vivo reduction of the oxidation parameters. The lag time in the formation of conjugated dienes during copper-mediated oxidation, the aggregation state of LDL, and the presence of anti-oxidized LDL antibodies were measured. The presence of oxidized proteins in tissues and the presence of oxidation-specific epitopes in heart sections of atherosclerotic lesions were also analyzed. Except for lag time, the results showed that the oxidation parameters were reduced in the apoA-IV/E-o mice compared with the apoE(o) mice. This suggests that human apoA-IV acts in vivo as an antioxidant, In addition, human apoA-IV accumulation was detected in the atherosclerotic lesions of apoA-IV/E-o mice, suggesting that apoA-IV may inhibit oxidative damage to local tissues, thus decreasing the progression of atherosclerosis.
引用
收藏
页码:1023 / 1028
页数:6
相关论文
共 33 条
[1]   LESIONED LOW-DENSITY-LIPOPROTEIN IN ATHEROSCLEROTIC APOLIPOPROTEIN E-DEFICIENT TRANSGENIC MICE AND IN HUMANS IS OXIDIZED AND AGGREGATED [J].
AVIRAM, M ;
MAOR, I ;
KEIDAR, S ;
HAYEK, T ;
OIKNINE, J ;
BAREL, Y ;
ADLER, Z ;
KERTZMAN, V ;
MILO, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) :501-513
[2]   Regulation of the human apolipoprotein AIV gene expression in transgenic mice [J].
Baralle, M ;
Vergnes, L ;
Muro, AF ;
Zakin, MM ;
Baralle, FE ;
Ochoa, A .
FEBS LETTERS, 1999, 445 (01) :45-52
[3]   THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J].
BJORKHEM, I ;
HENRIKSSONFREYSCHUSS, A ;
BREUER, O ;
DICZFALUSY, U ;
BERGLUND, L ;
HENRIKSSON, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :15-22
[4]  
BROUSSEAU T, 1993, CLIN CHEM, V39, P960
[5]   CARBONIC ANHYDRASE-III - OXIDATIVE MODIFICATION IN-VIVO AND LOSS OF PHOSPHATASE-ACTIVITY DURING AGING [J].
CABISCOL, E ;
LEVINE, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14742-14747
[6]   Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV [J].
Cohen, RD ;
Castellani, LW ;
Qiao, JH ;
VanLenten, BJ ;
Lusis, AJ ;
Reue, K .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1906-1916
[7]   Protection against atherogenesis in mice mediated by human apolipoprotein A-IV [J].
Duverger, N ;
Tremp, G ;
Caillaud, JM ;
Emmanuel, F ;
Castro, G ;
Fruchart, JC ;
Steinmetz, A ;
Denefle, P .
SCIENCE, 1996, 273 (5277) :966-968
[8]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[9]   Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum [J].
Fournier, N ;
Atger, V ;
Paul, JL ;
Sturm, M ;
Duverger, N ;
Rothblat, GH ;
Moatti, N .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (05) :1283-1292
[10]  
Fruebis J, 1997, J LIPID RES, V38, P2455